Carbomedics Prosthetic Heart Valve; Carbomedics Supra-annular Prosthetic Heart Valve; Carbo-Seal Ascending Aortic Pros
Corcym S.r.l. · Decision date Dec 17, 2025
What did the FDA decide?
FDA records P900060/S069 as a supplement to PMA P900060, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 17, 2025.
FDA approval order statement
removal of an in-process inspection performed on valve sub-assemblies during the manufacturing process
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 17, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P900060/S069
- Regulatory pathway
- PMA supplement
- Applicant
- Corcym S.r.l.
- Product code
- LWQ
- Decision code
- OK30
- Decision date
- Dec 17, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: HEART-VALVE, MECHANICAL.
- Applicant
- Corcym S.r.l.
- Product code
- LWQ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P900060/S069 received
Application receipt date recorded by FDA.
P900060/S069 · FDA decision
30-Day Notice
P900060/S070 · Related supplement
CARBOMEDICS PROSTHETIC HEART VALVE, CARBOMEDICS SUPRA-ANNULAR PROSTHETIC HEART VALVE, OPTIFORM PROSTHETIC MITRAL HEART
Timeline entries are records held by MedtechLedger for P900060. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P900060
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Corcym S.r.l. | PMA supplement | Jul 28, 2026 | FDA |
Explore the linked device profile
Other records with product code LWQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| On-X Life Technologies, Inc. | PMA supplement | Aug 4, 2026 | FDA | |
| On-X Life Technologies, Inc. | PMA supplement | Jul 27, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Jun 11, 2026 | FDA | |
| On-X Life Technologies, Inc. | PMA supplement | Jan 5, 2026 | FDA | |
On-X Ascending Aortic ProsthesisP000037/S067 | On-X Life Technologies, Inc. | PMA supplement | Dec 17, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Corcym S.r.l.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Via Crescentino Sn, Saluggia, 13040
Sources and methodology
- Original FDA record: P900060/S069
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
